https://www.ophthalmologytimes.com/view/alcon-announces-acquisition-of-staar-surgical-evo-icl-lenses 2025-08-07 0.50 https://www.ophthalmologytimes.com/view/nice-announces-uk-approval-of-idebenone-for-treatment-of-leber-hereditary-optic-neuropathy 2025-08-15 0.50 https://www.ophthalmologytimes.com/view/diabetes-remission-glp-1-therapies-long-term-outcomes-diabetic-retinopathy 2025-08-06 0.50 https://www.ophthalmologytimes.com/view/feasibility-of-artificial-intelligence-in-leading-glaucoma-care 2025-08-05 0.50 https://www.ophthalmologytimes.com/view/managing-monitoring-romania-retinoblastoma-enhanced-screenings-unified-registry 2025-08-05 0.50 https://www.ophthalmologytimes.com/view/opus-genetics-global-rdh12-alliance-announce-new-collaboration 2025-08-01 0.50 https://www.ophthalmologytimes.com/view/topcon-expands-artificial-intelligence-ai-portfolio-with-iris-intelligent-retinal-imaging-systems-acquisition 2025-07-30 0.50 https://www.ophthalmologytimes.com/view/evaluating-the-clinical-performance-of-zeiss-at-elana-and-the-new-elisa-approach 2025-08-28 0.50 https://www.ophthalmologytimes.com/view/exonate-announced-clear-de-trial-for-exn407 2025-07-29 0.50 https://www.ophthalmologytimes.com/view/re-vana-revana-therapeutics-boehringer-ingelheim-collaboration-licensing-partnership-extended-release-ocular-therapy-eye 2025-07-29 0.50 https://www.ophthalmologytimes.com/view/biomarkers-microvascular-retinal-perfusion-coronary-heart-disease-oct-angiography-cardiovascular-cardiology 2025-07-28 0.50 https://www.ophthalmologytimes.com/view/alteogen-receives-positive-chmp-opinion-for-aflibercept-biosimilar-eyluxvi-ema-decision 2025-07-28 0.50 https://www.ophthalmologytimes.com/view/mucormycosis-infection-fungal-vision-in-diabetic-patient-cranial-nerve-palsy 2025-07-25 0.50 https://www.ophthalmologytimes.com/view/three-ways-we-re-building-confidence-through-evidence-in-myopia-management 2025-07-25 0.50 https://www.ophthalmologytimes.com/view/ema-grants-orphan-designation-to-adx-2191-aldeyra-therapeutics-for-inherited-retinal-dystrophies 2025-07-24 0.50 https://www.ophthalmologytimes.com/view/nicox-and-kowa-enter-commercialisation-agreement-for-ncx-470-glaucoma-eye-drop 2025-07-23 0.50 https://www.ophthalmologytimes.com/view/germany-serves-as-european-launch-point-for-low-dose-atropine-from-santen-ryjunea- 2025-07-22 0.50 https://www.ophthalmologytimes.com/view/ai-powered-eye2gene-uses-multimodal-imaging-to-diagnose-inherited-retinal-disease 2025-07-18 0.50 https://www.ophthalmologytimes.com/view/q-a-early-research-findings-and-clinical-experiences-with-a-new-multifocal-iol 2025-07-17 0.50 https://www.ophthalmologytimes.com/view/could-targeting-retinal-non-perfusion-be-the-key-to-achieving-true-disease-modification-in-diabetic-retinopathy 2025-07-17 0.50 https://www.ophthalmologytimes.com/view/secondhand-smoke-is-environmental-risk-factor-in-myopia-development-study-suggests 2025-07-16 0.50 https://www.ophthalmologytimes.com/view/new-microbial-strain-produces-high-yields-of-lutein-for-amd-cataract-prevention 2025-07-15 0.50 https://www.ophthalmologytimes.com/view/real-world-insights-with-eylea-8mg 2025-07-11 0.50 https://www.ophthalmologytimes.com/view/study-data-link-cannabis-use-to-lower-risk-of-proliferative-vitreoretinopathy-after-retinal-detachment-repair 2025-07-22 0.50 https://www.ophthalmologytimes.com/view/alcon-s-clareon-panoptix-pro-iol-approved-in-canada-for-cataract-patients 2025-07-11 0.50 https://www.ophthalmologytimes.com/view/fda-agrees-to-expand-atsena-s-gene-therapy-trial-for-xlrs-treatment 2025-07-10 0.50 https://www.ophthalmologytimes.com/view/health-canada-approves-aflibercept-biosimilar-aflivu 2025-07-10 0.50 https://www.ophthalmologytimes.com/view/clareon-panoptix-pro-iol-alcon-approved-in-canada 2025-06-26 0.50 https://www.ophthalmologytimes.com/view/perfuse-therapeutics-shares-phase-2-clinical-findings-from-glaucoma-and-diabetic-retinopathy-trials-of-per-001 2025-06-26 0.50 https://www.ophthalmologytimes.com/view/precautionary-class-2-medicines-recall-of-zaditen-0-25-mg-ml-eye-drops-solution-issued 2025-07-08 0.50 https://www.ophthalmologytimes.com/view/nationwide-free-transport-for-cataract-patients-through-spamedica 2025-07-07 0.50 https://www.ophthalmologytimes.com/view/breye-therapeutics-completes-phase-1b-trial-of-danegaptide-oral-therapy-for-non-proliferative-diabetic-retinopathy 2025-06-26 0.50 https://www.ophthalmologytimes.com/view/heidelberg-engineering-launches-zinserlab-innovation-hub-expands-orbis-collaboration 2025-07-10 0.50 https://www.ophthalmologytimes.com/view/long-duration-spaceflight-tests-the-limits-of-telemedicine-nasa-iss-ocular-imaging-international-spectralis-symposium 2025-06-26 0.50 https://www.ophthalmologytimes.com/view/interdisciplinary-report-illuminates-demographic-systemic-health-factors-of-dry-eye-disease-tfos-dews-iii 2025-06-25 0.50 https://www.ophthalmologytimes.com/view/patients-with-high-genetic-risk-of-dry-amd-should-avoid-instant-coffee-investigators-say-age-related-macular-degeneration 2025-06-25 0.50 https://www.ophthalmologytimes.com/view/how-a-newly-defined-category-of-iols-can-benefit-patient-outcomes 2025-06-25 0.50 https://www.ophthalmologytimes.com/view/european-commission-grants-label-extension-for-eylea-8-mg-with-extended-6-month-treatment-interval 2025-07-08 0.50 https://www.ophthalmologytimes.com/view/international-spectralis-symposium-outer-retinal-disease-histology-oct-christine-curcio-phd 2025-06-25 0.50 https://www.ophthalmologytimes.com/view/iridex-enrolls-first-patient-in-study-evaluating-micropulse-technology-as-an-adjunct-to-anti-vegf-therapy-for-dme 2025-06-25 0.50 https://www.ophthalmologytimes.com/view/custom-matching-iol-managing-patient-satisfaction-patient-selection-keratometry-values 2025-06-25 0.50 https://www.ophthalmologytimes.com/view/three-year-outcomes-of-aflibercept-8mg-in-neovascular-age-related-macular-degeneration-and-diabetic-macular-edema 2025-06-25 0.50 https://www.ophthalmologytimes.com/view/myopia-s-global-impact-by-the-numbers-prevalence-projection-quality-of-life 2025-07-07 0.50 https://www.ophthalmologytimes.com/view/a-new-set-of-guidelines-for-implementing-interventional-glaucoma-consensus-protocol 2025-06-24 0.50 https://www.ophthalmologytimes.com/view/the-significance-of-flio-in-diabetic-eye-disease-retina-scan-fluorescence-lifetime-imaging-ophthalmoscopy 2025-06-23 0.50 https://www.ophthalmologytimes.com/view/srinivas-r-sadda-retina-presentation-international-spectralis-symposium-amd-age-related-macular-degeneration 2025-06-19 0.50 https://www.ophthalmologytimes.com/view/fluorescence-lifetime-imaging-ophthalmoscopy-flio-reveals-the-brain-neuroophthalmology-ophthalmic-imaging-spectralis-symposium 2025-06-18 0.50 https://www.ophthalmologytimes.com/view/the-bold-future-of-imaging-lies-in-the-anterior-segment-says-rayaz-malik-mbchb-phd-iss-international-heidelberg-spectralis-symposium 2025-06-18 0.50 https://www.ophthalmologytimes.com/view/johnson-johnson-launches-presbyopia-correcting-tecnis-odyssey-iol-in-europe-middle-east-canada-intraocular-lens 2025-06-17 0.50 https://www.ophthalmologytimes.com/view/how-remote-retinal-imaging-raises-the-bar-across-service-research-and-education-baljean-dhillon-international-spectralis-symposium 2025-06-13 0.50 https://www.ophthalmologytimes.com/view/modern-monitoring-strategies-remove-major-barriers-to-retina-care-anat-loewenstein-international-spectralis-symposium 2025-06-13 0.50 https://www.ophthalmologytimes.com/view/differentiating-physiology-from-pathology-in-the-paediatric-vitreous-international-spectralis-symposium-hyperreflective-phvo 2025-06-13 0.50 https://www.ophthalmologytimes.com/view/tyson-brunstetter-od-phd-shares-key-takeaways-from-his-keynote-at-the-international-spectralis-symposium-beyond-nasa-astronaut 2025-06-12 0.50 https://www.ophthalmologytimes.com/view/imaging-the-ellipsoid-zone-line-could-change-the-global-approach-to-clinical-trials-robyn-guymer-international-spectralis-symposium-iss 2025-06-13 0.50 https://www.ophthalmologytimes.com/view/neeraj-dhaun-md-phd-says-advances-in-oct-tech-may-positively-impact-patients-with-chronic-kidney-disease 2025-06-12 0.50 https://www.ophthalmologytimes.com/view/gereon-h-ttmann-phd-introduces-holographic-oct-to-a-new-audience-iss-international-spectralis-symposium-optical-coherence-tomography 2025-06-13 0.50 https://www.ophthalmologytimes.com/view/the-cornea-is-the-unsung-hero-of-diagnosing-neurodegeneration-says-rayaz-malik-mbchb-phd-neurodegenerative-disease-international-spectralis-symposium-iss 2025-06-18 0.50 https://www.ophthalmologytimes.com/view/ruth-hogg-phd-says-nicola-data-emphasise-the-value-of-multicolor-images-international-spectralis-symposium-retina 2025-06-12 0.50 https://www.ophthalmologytimes.com/view/resident-and-consultant-ophthalmologists-compare-immediate-sequential-bilateral-cataract-surgery-successes-isbcs 2025-06-26 0.50 https://www.ophthalmologytimes.com/view/zeteo-biomedical-receives-new-eu-and-us-patents-for-its-drug-delivery-technologies 2025-06-11 0.50 https://www.ophthalmologytimes.com/view/case-report-examines-corneal-perforation-associated-with-tyrosine-kinase-inhibitor 2025-06-09 0.50 https://www.ophthalmologytimes.com/view/full-list-of-topics-at-the-upcoming-international-spectralis-symposium 2025-06-19 0.50 https://www.ophthalmologytimes.com/view/new-dry-eye-disease-study-compares-two-preservative-free-artificial-tear-drops-soe-european-society-ophthalmology-portugal-lisbon 2025-06-06 0.50 https://www.ophthalmologytimes.com/view/keynote-lectures-and-yo-sessions-at-the-2025-soe-congress-european-society-ophthalmology 2025-06-06 0.50 https://www.ophthalmologytimes.com/view/the-european-society-of-ophthalmology-soe-meeting-kicks-off-in-lisbon-portugal-june-2025 2025-06-06 0.50 https://www.ophthalmologytimes.com/view/brazil-s-anvisa-grants-marketing-authorization-to-lucentis-biosimilar-fyb201-ranivisio-bioeq-ag-ranibizumab-genentech-formycon-fyb201 2025-06-12 0.50 https://www.ophthalmologytimes.com/view/european-commission-approves-low-dose-atropine-eye-drop-ryjunea-santen-announces-ema-sydnexis-syd-101-paediatric-myopia 2025-06-05 0.50 https://www.ophthalmologytimes.com/view/eylea-8mg-in-focus-key-learnings-from-the-pivotal-trials 2025-06-03 0.50 https://www.ophthalmologytimes.com/view/an-implantable-option-bridges-the-gap-for-patients-with-amd-cover-story-macular-iol 2025-06-04 0.50 https://www.ophthalmologytimes.com/view/genetic-distinctions-reticular-pseudodrusen-drusen-genome-wide-association-study-novel-genetic-loci 2025-06-03 0.50 https://www.ophthalmologytimes.com/view/pinpointing-a-first-line-treatment-for-glaucoma-laser-therapy-slt-dslt 2025-06-03 0.50 https://www.ophthalmologytimes.com/view/eu-issues-ce-mark-for-ai-therapy-planning-assistant-from-deepeye-medical 2025-05-30 0.50 https://www.ophthalmologytimes.com/view/essilorluxottica-acquires-optegra-clinics-with-support-from-mideuropa 2025-05-30 0.50 https://www.ophthalmologytimes.com/view/metabolomic-profiling-could-identify-stage-specific-diabetic-retinopathy-biomarkers 2025-05-29 0.50 https://www.ophthalmologytimes.com/view/early-uveitis-detection-and-intervention-is-key-to-treatment-vision-preservation 2025-05-28 0.50 https://www.ophthalmologytimes.com/view/early-intervention-is-crucial-for-long-term-outcomes-in-paediatric-gene-therapy 2025-05-27 0.50 https://www.ophthalmologytimes.com/view/research-indicates-b-vitamins-and-choline-provide-neuroprotection-against-glaucoma-retinal-ganglion-cell-death-degeneration 2025-05-23 0.50 https://www.ophthalmologytimes.com/view/ascrs-2025-robert-ang-md-explains-why-a-small-aperture-iol-is-not-a-niche-product- 2025-05-23 0.50 https://www.ophthalmologytimes.com/view/jorge-ali-md-phd-febophth-fwcrs-receives-2024-international-research-excellence-award 2025-05-23 0.50 https://www.ophthalmologytimes.com/view/ema-issues-ce-mark-for-dream-oct-from-intalight 2025-05-21 0.50 https://www.ophthalmologytimes.com/view/arvo-2025-ocular-and-systemic-mitochondrial-diseases-may-be-key-to-dementia-diagnosis 2025-05-20 0.50 https://www.ophthalmologytimes.com/view/research-links-covid-19-to-prevalence-and-severity-of-paediatric-astigmatism 2025-05-20 0.50 https://www.ophthalmologytimes.com/view/topline-results-from-investigational-namd-drop-syl1801-sylentis- 2025-05-20 0.50 https://www.ophthalmologytimes.com/view/how-patients-navigate-quality-of-life-challenges-associated-with-geographic-atrophy 2025-05-15 0.50 https://www.ophthalmologytimes.com/view/aavantgarde-bio-presents-positive-data-for-retinitis-pigmentosa-and-stargardt-disease-therapies 2025-05-12 0.50 https://www.ophthalmologytimes.com/view/eyecool-therapeutics-announces-results-from-pilot-study-of-novel-chronic-ocular-surface-pain-treatment 2025-05-12 0.50 https://www.ophthalmologytimes.com/view/retinal-microvascular-changes-in-patients-with-systemic-lupus-erythematosus-importance-of-octa 2025-05-09 0.50 https://www.ophthalmologytimes.com/view/topcon-healthcare-inc-appoints-krysten-williams-head-of-digital-solutions-clinical-development-emea 2025-05-08 0.50 https://www.ophthalmologytimes.com/view/bausch-lomb-s-luxlife-iol-receives-ce-mark-approval 2025-05-08 0.50 https://www.ophthalmologytimes.com/view/tepezza-receives-marketing-authorisation-from-mhra 2025-05-09 0.50 https://www.ophthalmologytimes.com/view/arvo-2025-alfredo-sadun-md-phd-says-later-is-better-in-some-patients-with-lhon-leber-hereditary-optic-neuropathy 2025-05-07 0.50 https://www.ophthalmologytimes.com/view/moorfields-topcon-ioo-announce-partnership-launch-of-cascader 2025-05-07 0.50 https://www.ophthalmologytimes.com/view/isarna-therapeutics-shares-positive-results-from-phase-2-better-trial 2025-05-07 0.50 https://www.ophthalmologytimes.com/view/arvo-2025-nitish-mehta-md-provides-real-world-insights-from-aflibercept-8-mg-for-treatment-naive-diabetic-macular-oedema 2025-05-07 0.50 https://www.ophthalmologytimes.com/view/opgx-lca5-gene-therapy-phase-1-2-data-support-potential-to-restore-meaningful-vision 2025-05-06 0.50 https://www.ophthalmologytimes.com/view/q-a-gregory-moloney-franzco-frcsc-discusses-the-monofocal-plus-toric-intraocular-lens 2025-05-06 0.50 https://www.ophthalmologytimes.com/view/arvo-2025-anat-loewenstein-md-and-a-cohort-of-colleagues-on-meeting-patients-needs-diabetic-macular-oedema-retinopathy 2025-05-05 0.50 https://www.ophthalmologytimes.com/view/editorial-advisory-board-members-bring-research-findings-to-arvo-association-research-vision-ophthalmology 2025-05-05 0.50 https://www.ophthalmologytimes.com/view/zeiss-debuts-research-data-platform-highlights-boehringer-ingelheim-partnership 2025-05-02 0.50 https://www.ophthalmologytimes.com/view/luxia-receives-ce-mdr-certification 2025-04-30 0.50 https://www.ophthalmologytimes.com/view/ema-chmp-adopts-positive-opinion-for-teprotumumab-tepezza-amgen-marketing-authorisation-application 2025-04-30 0.50 https://www.ophthalmologytimes.com/view/the-future-of-microbial-keratitis-treatment-ultraviolet-light-therapy-ocular-surface-eyelid-care 2025-04-29 0.50 https://www.ophthalmologytimes.com/view/daniela-ferrara-appointed-by-topcon-healthcare-as-cmo 2025-04-28 0.50 https://www.ophthalmologytimes.com/view/sheng-lim-md-frcophth-brings-data-from-the-concept-study-to-the-ascrs-meeting 2025-04-29 0.50 https://www.ophthalmologytimes.com/view/vision--and-life-threatening-neuro-ophthalmological-presentations 2025-04-25 0.50 https://www.ophthalmologytimes.com/view/diagnosing-types-of-dry-eye-in-patients-with-autoimmune-disease 2025-04-23 0.50 https://www.ophthalmologytimes.com/view/entod-pharmaceuticals-announces-cdsco-approval-of-0-05-atropine-drops-myatro-xl- 2025-04-24 0.50 https://www.ophthalmologytimes.com/view/investigating-causes-of-diplopia-to-minimise-morbidity-and-mortality 2025-04-22 0.50 https://www.ophthalmologytimes.com/view/neurotech-appoints-beth-marsh-as-chief-commercial-officer-ahead-of-us-product-launch 2025-04-22 0.50 https://www.ophthalmologytimes.com/view/new-trends-in-the-diagnosis-of-dry-eye-disease-a-patient-centric-approach 2025-04-21 0.50 https://www.ophthalmologytimes.com/view/regeneron-announces-us-fda-complete-response-letter-for-aflibercept-8-mg-eylea-hd-supplemental-biologics-license-application 2025-04-21 0.50 https://www.ophthalmologytimes.com/view/industry-updates-and-clinical-trial-data-at-the-2025-arvo-annual-meeting 2025-04-18 0.50 https://www.ophthalmologytimes.com/view/dmo-study-meta-analysis-illuminates-how-racial-subgroups-are-underrepresented-in-clinical-trials 2025-04-17 0.50 https://www.ophthalmologytimes.com/view/artificial-intellgence-analyses-biomarker-changes-in-neovascular-amd-treated-with-faricimab 2025-04-18 0.50 https://www.ophthalmologytimes.com/view/clinicians-may-improve-follow-up-adherence-by-leveraging-social-media-apps-congenital-ectopic-lentis-wechat 2025-04-16 0.50 https://www.ophthalmologytimes.com/view/journal-of-neuroinflammation-publishes-data-on-eleva-s-lead-retinal-asset-cpv-104 2025-04-15 0.50 https://www.ophthalmologytimes.com/view/alcon-marks-110th-anniversary-of-grieshaber-ag-site-in-switzerland 2025-04-15 0.50 https://www.ophthalmologytimes.com/view/eyestem-research-announces-positive-results-from-phase-1-geographic-atrophy-trial-eyecyte-rpe-arvo 2025-04-14 0.50 https://www.ophthalmologytimes.com/view/when-will-gene-therapy-pipeline-retinal-disease-cell-age-related-macular-degenerationbe-ready-for-patients-with-amd- 2025-04-14 0.50 https://www.ophthalmologytimes.com/view/a-turning-point-in-retinal-neovascular-diseases 2025-04-11 0.50 https://www.ophthalmologytimes.com/view/antibody-drug-discovery-company-novelty-nobility-joins-johnson-johnson-jlabs-korea 2025-04-15 0.50 https://www.ophthalmologytimes.com/view/tiktok-instagram-reels-and-other-short-form-videos-linked-to-negative-ocular-health-outcomes-dry-eye-myopia-glasses-strain 2025-04-10 0.50 https://www.ophthalmologytimes.com/view/uk-surgeon-performs-30-000th-laser-eye-procedure-david-gartry-moorfields 2025-04-10 0.50 https://www.ophthalmologytimes.com/view/bayer-submits-ema-application-for-aflibercept-8mg-third-indication-retinal-vein-occlusion 2025-04-18 0.50 https://www.ophthalmologytimes.com/view/rethinking-race-as-a-risk-factor-for-glaucoma 2025-04-08 0.50 https://www.ophthalmologytimes.com/view/european-commission-expands-upadacitinib-rinvoq-indication-to-include-giant-cell-arteritis 2025-04-08 0.50 https://www.ophthalmologytimes.com/view/tenpoint-therapeutics-submits-us-fda-new-drug-application-for-presbyopia-treatment-brimochol-pf 2025-04-08 0.50 https://www.ophthalmologytimes.com/view/paediatric-patients-with-early-onset-atopic-dermatitis-show-higher-uveitis-risk 2025-04-07 0.50 https://www.ophthalmologytimes.com/view/canalicular-gel-lacrifill-nordic-pharma-receives-ce-mark 2025-04-07 0.50 https://www.ophthalmologytimes.com/view/a-real-world-study-of-an-ai-system-for-enhanced-detection-of-diabetic-retinopathy-artificial-intelligence-fundus-aireen 2025-04-04 0.50 https://www.ophthalmologytimes.com/view/a-panel-discussion-on-extended-treatment-intervals-in-retinal-therapy-breaks-the-mold-at-cophy-2025 2025-04-04 0.50 https://www.ophthalmologytimes.com/view/cophy-2025-anat-loewenstein-debate-discussion-format-sympoisum-clinical-pearls 2025-04-04 0.50 https://www.ophthalmologytimes.com/view/surgical-medical-and-next-generation-retina-topics-at-cophy 2025-04-04 0.50 https://www.ophthalmologytimes.com/view/retina-recap-ema-and-us-fda-approvals-march-2025 2025-04-03 0.50 https://www.ophthalmologytimes.com/view/us-fda-issues-second-complete-response-letter-for-dry-eye-drug-reproxalap-aldeyra-therapeutics- 2025-04-03 0.50 https://www.ophthalmologytimes.com/view/opthea-discontinues-coast-and-shore-sozinibercept-combination-therapy-trials 2025-04-02 0.50 https://www.ophthalmologytimes.com/view/french-ophtamyop-study-reveals-trends-in-myopia-control 2025-04-03 0.50 https://www.ophthalmologytimes.com/view/ema-grants-positive-chmp-opinion-for-low-dose-atropine-paediatric-myopia-syd-101-ryjunea-sydnexis- 2025-04-01 0.50 https://www.ophthalmologytimes.com/view/new-study-investigates-ocular-involvement-in-multiple-myeloma 2025-04-01 0.50 https://www.ophthalmologytimes.com/view/clinical-outcomes-and-patient-satisfaction-achieved-with-a-corneal-approach-for-managing-presbyopia-a-case-with-special-significance 2025-04-01 0.50 https://www.ophthalmologytimes.com/view/clinicians-are-up-for-debate-at-cophy-congress-on-controversies-in-ophthalmology-seville-spain 2025-04-04 0.50 https://www.ophthalmologytimes.com/view/international-study-illuminates-economic-burden-of-late-stage-age-related-macular-degeneration 2025-03-28 0.50 https://www.ophthalmologytimes.com/view/accommodative-intraocular-lenses-are-they-coming-back-refractive-trend 2025-03-28 0.50 https://www.ophthalmologytimes.com/view/paediatric-myopia-study-indicates-lens-thickness-and-power-changes-closely-associated-with-age 2025-03-28 0.50 https://www.ophthalmologytimes.com/view/alcon-acquires-majority-interest-in-cell-therapy-company-aurion-biotech-provides-operational-updates 2025-03-27 0.50 https://www.ophthalmologytimes.com/view/internal-limiting-membrane-staining-dye-ilm-blue-dorc-receives-nmpa-approval-in-china 2025-03-27 0.50 https://www.ophthalmologytimes.com/view/association-between-ophthalmic-vascular-and-neural-structures-and-fibromyalgia-syndrome 2025-03-26 0.50 https://www.ophthalmologytimes.com/view/nanoscope-therapeutics-publishes-clinical-results-of-mco-010-findings-for-patients-with-retinitis-pigmentosa 2025-03-26 0.50 https://www.ophthalmologytimes.com/view/alcon-clareon-vivity-iol-receives-ce-mark-european-commercialisation-announced-edof-toric-lens 2025-03-25 0.50 https://www.ophthalmologytimes.com/view/moorfields-eye-hospital-announces-insight-research-hub-will-collaborate-with-ai-drug-pharmaceutical-artificial-intelligence-development-company-insitro 2025-03-24 0.50 https://www.ophthalmologytimes.com/view/phase-3-coast-trial-fails-to-meet-primary-endpoints-for-wet-amd-opthea-reports 2025-03-24 0.50 https://www.ophthalmologytimes.com/view/study-examines-real-world-treat-and-extend-outcomes-and-background-factors-of-macular-atrophy 2025-03-21 0.50 https://www.ophthalmologytimes.com/view/increased-paediatric-astigmatism-prevalence-and-severity-after-covid-19 2025-03-21 0.50 https://www.ophthalmologytimes.com/view/researchers-raise-awareness-of-macular-pathologies-which-mimic-amd-and-ga 2025-03-20 0.50 https://www.ophthalmologytimes.com/view/three-researchers-receive-2025-arvo-association-research-vision-ophthalmology-foundation-early-career-clinician-scientist-awards 2025-03-18 0.50 https://www.ophthalmologytimes.com/view/bausch-lomb-launches-arise-orthokeratology-lens-fitting-system-in-europe-uk-and-us 2025-03-17 0.50 https://www.ophthalmologytimes.com/view/edi-oct-and-cvi-findings-can-shed-light-on-choroidal-vascular-physiology-following-covid-19-pneumonia-vascular-imaging 2025-03-13 0.50 https://www.ophthalmologytimes.com/view/winterthur-switzerland-welcomes-second-annual-winterthur-ophthalmology-symposium 2025-03-14 0.50 https://www.ophthalmologytimes.com/view/study-assesses-efficacy-of-cyclosporine-a-0-1-cationic-emulsion-drops-for-postoperative-cataract-surgery-discomfort 2025-03-13 0.50 https://www.ophthalmologytimes.com/view/first-patient-dosed-in-phase-1-2-astra-study-for-stargardt-disease-therapy-sb-007-splicebio- 2025-03-13 0.50 https://www.ophthalmologytimes.com/view/new-gender-and-genetic-factors-linked-to-fuchs-endothelial-corneal-dystrophy 2025-03-13 0.50 https://www.ophthalmologytimes.com/view/her-royal-highness-the-duchess-of-edinburgh-delivers-keynote-address-on-gender-equity-in-eye-care 2025-03-14 0.50 https://www.ophthalmologytimes.com/view/advanced-therapies-in-neovascular-amd-and-dmo-experts-weigh-in 2025-03-11 0.50 https://www.ophthalmologytimes.com/view/okyo-pharma-files-us-fda-fast-track-application-for-neuropathic-corneal-pain-treatment-urcosimod 2025-03-11 0.50 https://www.ophthalmologytimes.com/view/renal-dysfunction-negatively-impacts-effect-of-diabetic-macular-oedema-therapy 2025-03-10 0.50 https://www.ophthalmologytimes.com/view/mactel-is-probably-more-common-than-we-know-say-experts-following-revakinagene-taroretcel-lwey-approval 2025-03-10 0.50 https://www.ophthalmologytimes.com/view/nicox-sa-shares-research-findings-from-ncx-470-mont-blanc-phase-3-glaucoma-trial 2025-03-07 0.50 https://www.ophthalmologytimes.com/view/heidelberg-engineering-announces-two-day-international-spectralis-symposium-register-germany-meeting-conference 2025-06-09 0.50 https://www.ophthalmologytimes.com/view/the-fred-hollows-foundation-issues-a-call-to-action-for-international-women-s-day 2025-03-07 0.50 https://www.ophthalmologytimes.com/view/us-fda-approves-revakinagene-taroretcel-lwey-encelto-for-macular-telangiectasia-type-2 2025-03-06 0.50 https://www.ophthalmologytimes.com/view/enhancing-the-patient-journey-solutions-for-confident-refractive-planning-and-follow-up 2025-03-05 0.50 https://www.ophthalmologytimes.com/view/enhancing-the-patient-journey-solutions-to-overcoming-challenges-in-glaucoma-management 2025-03-05 0.50 https://www.ophthalmologytimes.com/view/enhancing-the-patient-journey-solutions-for-streamlining-success-in-cataract-surgery 2025-03-05 0.50 https://www.ophthalmologytimes.com/view/enhancing-the-patient-journey-solutions-for-confident-refractive-planning-and-follow-up-1 2025-03-05 0.50 https://www.ophthalmologytimes.com/view/enhancing-the-patient-journey-solutions-for-effective-ga-management-1 2025-03-05 0.50 https://www.ophthalmologytimes.com/view/enhancing-the-patient-journey-solutions-for-effective-ga-management 2025-03-05 0.50 https://www.ophthalmologytimes.com/view/comparing-postoperative-astigmatism-following-toric-iol-implantation-and-femtosecond-laser-assisted-astigmatic-keratotomy 2025-03-04 0.50 https://www.ophthalmologytimes.com/view/ema-provides-positive-atmp-opinion-for-gene-therapy-products-ocu410-and-ocu410st-ocugen-ga-stargardt-geographic-atrophy-amd 2025-03-04 0.50 https://www.ophthalmologytimes.com/view/novel-stem-cell-therapy-restores-corneal-damage-previously-believed-irreversible 2025-03-04 0.50 https://www.ophthalmologytimes.com/view/cognition-therapeutics-announces-publication-reviewing-potential-of-zervimesine-ct1812-in-dry-amd 2025-03-07 0.50 https://www.ophthalmologytimes.com/view/study-cigarette-smoking-negatively-affects-choroidal-vascularity 2025-03-07 0.50 https://www.ophthalmologytimes.com/view/association-between-the-triglyceride-glucose-index-and-central-retinal-artery-occlusion-predictive-biomarker 2025-02-28 0.50 https://www.ophthalmologytimes.com/view/australian-society-of-ophthalmologists-appoints-three-new-board-members 2025-02-28 0.50 https://www.ophthalmologytimes.com/view/preview-the-escrs-winter-meeting-comes-to-athens 2025-02-27 0.50 https://www.ophthalmologytimes.com/view/report-compares-rates-of-sexual-harassment-and-gendered-discrimination-in-ophthalmology 2025-02-27 0.50 https://www.ophthalmologytimes.com/view/ags-2025-clemens-strohmaier-phd-on-improving-aqueous-humour-outflow-following-excimer-laser-trabeculostomy 2025-02-27 0.50 https://www.ophthalmologytimes.com/view/zeiss-visumax-800-with-smile-pro-software-receives-nmpa-approval-in-china 2025-02-26 0.50 https://www.ophthalmologytimes.com/view/prevent-blindness-highlights-free-resources-during-retinopathy-of-prematurity-awareness-week 2025-02-26 0.50 https://www.ophthalmologytimes.com/view/study-demonstrates-early-outcomes-of-new-gene-therapy-for-aipl1-associated-inherited-retinal-dystrophies 2025-02-25 0.50 https://www.ophthalmologytimes.com/view/uk-mhra-issues-approval-for-formycon-aflibercept-biosimilar-fyb203-ahzantive- 2025-02-25 0.50 https://www.ophthalmologytimes.com/view/why-education-must-extend-beyond-patients-to-make-a-difference-in-diabetic-eye-disease 2025-02-24 0.50 https://www.ophthalmologytimes.com/view/new-research-illuminates-patient-dissatisfaction-despite-successful-restoration-of-vision-following-cataract-surgery 2025-02-24 0.50 https://www.ophthalmologytimes.com/view/alcon-launches-voyager-direct-selective-laser-trabeculoplasty-device-in-the-us 2025-02-21 0.50 https://www.ophthalmologytimes.com/view/impact-of-durable-therapies-on-patients-and-clinics-and-monitoring-strategies 2025-02-21 0.50 https://www.ophthalmologytimes.com/view/postoperative-considerations-for-retinal-detachments-following-keratoprosthesis-implantation 2025-02-20 0.50 https://www.ophthalmologytimes.com/view/ema-validates-indication-extension-application-of-pegcetacoplan-for-treatment-of-kidney-disease-chmp-approval 2025-02-20 0.50 https://www.ophthalmologytimes.com/view/hyperacute-outer-retinal-dysfunction-may-be-an-underrecognised-paediatric-disorder-fever-children 2025-02-19 0.50 https://www.ophthalmologytimes.com/view/heart-eye-announces-ai-driven-retinal-imaging-system-to-detect-biomarkers-of-cardiovascular-health-risks 2025-02-19 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-2025-the-global-forecast-for-ai-driven-home-oct-anat-loewenstein 2025-02-18 0.50 https://www.ophthalmologytimes.com/view/spamedica-and-vision-express-partner-for-uk-training-placement-programme 2025-02-18 0.50 https://www.ophthalmologytimes.com/view/gensight-biologics-shares-5-year-efficacy-and-safety-findings-from-reflect-phase-iii-gene-therapy-trial-lhon 2025-02-18 0.50 https://www.ophthalmologytimes.com/view/retinal-biomarkers-in-oct-imaging-may-have-predictive-applications-for-namd-age-related-macular-degeneration 2025-02-17 0.50 https://www.ophthalmologytimes.com/view/iol-design-puts-a-new-spin-on-vision 2025-02-18 0.50 https://www.ophthalmologytimes.com/view/study-shows-high-compliance-with-early-childhood-vision-screenings-pinpoints-parental-limitations 2025-02-14 0.50 https://www.ophthalmologytimes.com/view/strategies-for-loading-dose-sse-for-treatment-naive-and-switch-patients 2025-02-14 0.50 https://www.ophthalmologytimes.com/view/perspectives-on-the-usefulness-of-real-world-data 2025-02-14 0.50 https://www.ophthalmologytimes.com/view/veterinary-ophthalmology-can-foster-insights-and-progress-in-glaucoma-care 2025-05-02 0.50 https://www.ophthalmologytimes.com/view/an-accessible-free-resource-on-genetic-eye-disease-is-changing-patient-education 2025-02-07 0.50 https://www.ophthalmologytimes.com/view/healthy-lifestyles-translate-to-lower-risk-of-retinal-disease 2025-02-12 0.50 https://www.ophthalmologytimes.com/view/i-paul-singh-md-says-artificial-intelligence-will-help-glaucoma-specialists-make-decisions 2025-02-12 0.50 https://www.ophthalmologytimes.com/view/electrical-neurostimulation-shows-potential-as-an-innovative-glaucoma-therapy 2025-02-11 0.50 https://www.ophthalmologytimes.com/view/study-indicates-age-and-gender-are-factors-in-ocular-gene-therapy-outcomes 2025-02-10 0.50 https://www.ophthalmologytimes.com/view/ema-launches-procedure-for-manufacturers-working-with-high-risk-medical-devices 2025-02-10 0.50 https://www.ophthalmologytimes.com/view/helping-patients-with-glaucoma-manage-mental-health 2025-02-06 0.50 https://www.ophthalmologytimes.com/view/safety-profile-of-new-therapies 2025-02-07 0.50 https://www.ophthalmologytimes.com/view/outcomes-with-raricimab-and-choosing-between-the-new-therapies 2025-02-07 0.50 https://www.ophthalmologytimes.com/view/ocular-surface-disease-and-other-adverse-effects-linked-to-cosmetics-personal-care-products 2025-02-06 0.50 https://www.ophthalmologytimes.com/view/shifting-the-narrative-around-dry-eye-disease 2025-02-05 0.50 https://www.ophthalmologytimes.com/view/italian-study-illuminates-positive-outcomes-and-common-complications-of-sing-imt-implantation 2025-02-05 0.50 https://www.ophthalmologytimes.com/view/covid-19-may-impact-anatomy-of-retina-and-functional-vision 2025-02-05 0.50 https://www.ophthalmologytimes.com/view/crafting-an-international-database-for-retinopathy-of-prematurity 2025-02-05 0.50 https://www.ophthalmologytimes.com/view/a-new-home-treatment-for-amblyopia-binocular-eye-tracking-alternative-to-patching 2025-02-04 0.50 https://www.ophthalmologytimes.com/view/us-fda-approves-continuous-delivery-ranibizumab-treatment-susvimo-genentech-for-diabetic-macular-oedema 2025-02-04 0.50 https://www.ophthalmologytimes.com/view/nuance-audio-hearing-aid-glasses-receive-concurrent-ce-mark-and-fda-approval 2025-02-04 0.50 https://www.ophthalmologytimes.com/view/ocugen-inc-receives-european-medicines-agency-atmp-designation-for-new-gene-therapy 2025-03-04 0.50 https://www.ophthalmologytimes.com/view/european-medicines-agency-chmp-adopts-positive-opinions-for-two-aflibercept-biosimilars 2025-02-03 0.50 https://www.ophthalmologytimes.com/view/every-diopter-counts-when-it-comes-to-myopia-management-in-children- 2025-01-13 0.50 https://www.ophthalmologytimes.com/view/faricimab-molecular-design-and-role-of-ang-2 2025-01-31 0.50 https://www.ophthalmologytimes.com/view/novel-intravitreal-injections-faricimab-and-aflibercept-8mg-for-the-treatment-of-retinal-diseases 2025-01-31 0.50 https://www.ophthalmologytimes.com/view/patient-selection-for-aflibercept-8-mg 2025-01-31 0.50 https://www.ophthalmologytimes.com/view/adverse-events-of-the-port-delivery-system-and-addressing-challenges-with-adoption 2025-01-31 0.50 https://www.ophthalmologytimes.com/view/viralgen-and-axovia-therapeutics-enter-partnership-target-retinal-dystrophy-in-bardet-biedl-syndrome 2025-01-30 0.50 https://www.ophthalmologytimes.com/view/seabelife-announces-preclinical-efficacy-results-for-sbl03-topical-ophthalmic-gel 2025-01-30 0.50 https://www.ophthalmologytimes.com/view/study-identifies-associations-between-childhood-unilateral-amblyopia-and-cardiometabolic-disorders 2025-01-30 0.50 https://www.ophthalmologytimes.com/view/patient-experiences-key-clinical-trial-outcomes-of-the-port-delivery-system 2025-01-29 0.50 https://www.ophthalmologytimes.com/view/key-steps-in-the-surgical-implantation-of-the-port-delivery-system 2025-01-29 0.50 https://www.ophthalmologytimes.com/view/hoya-vision-care-expands-miyosmart-spectacle-lens-power-range-to-offer-broader-range-of-negative-and-cylindrical-powers 2025-01-29 0.50 https://www.ophthalmologytimes.com/view/apellis-pharmaceuticals-receives-australian-approval-of-pegcetacoplan-syfovre-for-treatment-of-geographic-atrophy 2025-01-28 0.50 https://www.ophthalmologytimes.com/view/deafblind-uk-and-birmingham-city-university-announce-education-and-research-centre 2025-01-27 0.50 https://www.ophthalmologytimes.com/view/macustar-receives-additional-ema-support-for-amd-clinical-study 2025-01-27 0.50 https://www.ophthalmologytimes.com/view/helios-trial-1-year-results-assess-implant-for-treatment-of-non-proliferative-diabetic-retinopathy 2025-01-24 0.50 https://www.ophthalmologytimes.com/view/study-design-for-pulsar-and-photon-trials-for-aflibercept-8-mg 2025-01-23 0.50 https://www.ophthalmologytimes.com/view/study-describes-triangle-sign-as-key-to-differentiating-total-choroidal-detachments-and-suprachoroidal-hemorrhages 2025-01-22 0.50 https://www.ophthalmologytimes.com/view/arctic-vision-receives-approval-in-australia-and-singapore-for-uveitic-macular-oedema-treatment-arvn001 2025-01-22 0.50 https://www.ophthalmologytimes.com/view/eylea-s-unique-moa-what-is-the-rationale-for-the-higher-molar-dose- 2025-05-06 0.50 https://www.ophthalmologytimes.com/view/neureye-research-team-leads-ai-supported-dementia-detection-programme-with-scottish-optometrists 2025-01-22 0.50 https://www.ophthalmologytimes.com/view/home-storage-of-anti-vegf-agents-presents-risk-of-temperature-changes-intravitreal-injection 2025-01-21 0.50 https://www.ophthalmologytimes.com/view/blink2-study-results-demonstrate-myopia-control-outcomes-following-multifocal-contact-lens-discontinuation 2025-01-21 0.50 https://www.ophthalmologytimes.com/view/icare-announces-updated-maia-truecolor-microperimetry-system-retina-geographic-atrophy-product-launch-imaging- 2025-01-20 0.50 https://www.ophthalmologytimes.com/view/artificial-intelligence-supports-screening-more-paediatric-patients-at-lower-cost 2025-01-21 0.50 https://www.ophthalmologytimes.com/view/significance-of-the-higher-molar-dose-of-aflibercept-8-mg 2025-01-23 0.50 https://www.ophthalmologytimes.com/view/plant-pathogen-macrophomina-phaseolina-may-be-emerging-cause-of-ocular-infection-in-humans 2025-01-17 0.50 https://www.ophthalmologytimes.com/view/considerations-for-surgical-implant-of-the-port-delivery-device-and-refill-process 2025-01-27 0.50 https://www.ophthalmologytimes.com/view/patient-selection-for-port-delivery-device 2025-01-28 0.50 https://www.ophthalmologytimes.com/view/overview-and-benefits-of-port-delivery-device-with-ranibizumab 2025-01-28 0.50 https://www.ophthalmologytimes.com/view/pulsesight-therapeutics-submits-clinical-trial-authorisation-for-phase-i-trial-of-pst-611 2025-01-16 0.50 https://www.ophthalmologytimes.com/view/rhygaze-announces-86-million-in-series-a-gene-therapy-switzerland-financing-for-optogenetic-vision-restoration-therapy-candidate 2025-01-17 0.50 https://www.ophthalmologytimes.com/view/the-zeiss-iol-power-calculation-service-providing-guidance-in-complex-cases 2025-02-03 0.50 https://www.ophthalmologytimes.com/view/us-fda-approves-zeiss-mel-90-excimer-laser-for-myopia-hyperopia-and-mixed-astigmatism 2025-01-14 0.50 https://www.ophthalmologytimes.com/view/teva-partners-with-klinge-biopharma-for-commercialisation-of-formycon-s-fyb203-biosimilar-aflibercept- 2025-02-05 0.50 https://www.ophthalmologytimes.com/view/bausch-lomb-launches-its-envista-aspire-monofocal-and-toric-intraocular-lenses-in-the-european-union 2025-01-13 0.50 https://www.ophthalmologytimes.com/view/study-explores-possible-applications-of-retinal-imaging-in-schizophrenia-detection-oct-psychology-neurology- 2025-01-10 0.50 https://www.ophthalmologytimes.com/view/assessing-new-therapies-for-retinal-diseases 2025-01-10 0.50 https://www.ophthalmologytimes.com/view/retinopathy-of-prematurity-rop-study-demonstrates-noninferiority-of-combination-microdrops-compared-to-standard-mydriatics 2025-01-07 0.50 https://www.ophthalmologytimes.com/view/vigeneron-receives-rare-paediatric-aav-germany-disease-designation-from-us-fda-for-retinitis-pigmentosa-gene-therapy-candidate-vg901 2025-01-08 0.50 https://www.ophthalmologytimes.com/view/conjunctival-bacteria-linked-to-higher-fluoroquinolone-antibiotic-ocular-resistance-in-new-study-from-brazil 2025-01-07 0.50 https://www.ophthalmologytimes.com/view/oculis-shares-phase-2-acuity-results-for-novel-neuroprotective-therapy-ocs-05 2025-01-07 0.50 https://www.ophthalmologytimes.com/view/regeneron-acquires-uk-biotech-company-oxular-broadening-retina-portfolio 2025-01-06 0.50 https://www.ophthalmologytimes.com/view/oct-and-octa-provide-insights-on-neuroretinal-changes-associated-with-fibromyalgia 2025-01-03 0.50 https://www.ophthalmologytimes.com/view/treat-and-extend-strategy-with-aflibercept 2025-01-03 0.50 https://www.ophthalmologytimes.com/view/international-restore-study-produces-results-of-genetic-therapy-for-leber-hereditary-optic-neuropathy 2025-01-03 0.50 https://www.ophthalmologytimes.com/view/uk-audit-explores-reasons-patients-skip-diabetic-retinopathy-screenings-treatment-diagnostic-compliance 2024-12-20 0.50 https://www.ophthalmologytimes.com/view/the-year-in-review-with-our-friends-from-modern-retina-eye-care-network 2024-12-19 0.50 https://www.ophthalmologytimes.com/view/ophthalmology-times-wraps-up-a-year-of-innovation-and-insight 2024-12-20 0.50 https://www.ophthalmologytimes.com/view/systane-ultra-pf-voluntary-recall-protecting-patients-from-potential-risks-of-fungal-material 2024-12-27 0.50 https://www.ophthalmologytimes.com/view/looking-back-at-2024-with-our-colleagues-eye-care-from-optometry-times 2024-12-19 0.50 https://www.ophthalmologytimes.com/view/wrapping-up-another-year-in-eye-care-2024-in-review 2024-12-26 0.50 https://www.ophthalmologytimes.com/view/finnish-researchers-report-on-registry-data-and-changing-workload-resulting-from-anti-vegf-therapies 2024-12-20 0.50 https://www.ophthalmologytimes.com/view/overview-of-novel-treatments-for-retinal-vascular-diseases 2025-01-28 0.50 https://www.ophthalmologytimes.com/view/see-the-best-of-our-print-edition-in-our-2024-in-cover-stories-roundup 2024-12-20 0.50 https://www.ophthalmologytimes.com/view/european-medicines-agency-will-assess-semaglutide-for-link-to-naion-ozempic-rare-eye-disease-glp-1-health-effects-vision 2024-12-20 0.50 https://www.ophthalmologytimes.com/view/shining-new-light-on-ocular-surface-care-low-level-light-therapy-for-dry-eye-disease-and-chalazion 2024-12-18 0.50 https://www.ophthalmologytimes.com/view/advantages-of-the-molecular-structure-of-aflibercept 2024-12-24 0.50 https://www.ophthalmologytimes.com/view/evolution-of-anti-vegf-agents-and-unmet-needs-in-retinal-diseases 2024-12-20 0.50 https://www.ophthalmologytimes.com/view/a-history-of-the-femtosecond-laser-in-the-united-states-and-europe 2024-12-17 0.50 https://www.ophthalmologytimes.com/view/balancing-the-promises-and-challenges-of-artificial-intelligence-ethics-best-practices-medicine-ophthalmology 2024-12-16 0.50 https://www.ophthalmologytimes.com/view/essilorluxottica-announces-agreement-for-acquisition-of-espansione-group 2024-12-17 0.50 https://www.ophthalmologytimes.com/view/a-neurologist-shares-his-warning-about-recurrent-optic-neuritis-attacks-and-nmosd-neuromyelitis-optica-spectrum-disorder 2024-12-16 0.50 https://www.ophthalmologytimes.com/view/ema-chmp-issues-positive-opinion-for-aflibercept-biosimilar-two-other-candidates-from-celltrion-european-medicines-agency-eydenzelt-reference-eylea 2024-12-16 0.50 https://www.ophthalmologytimes.com/view/putting-diagnostic-accuracy-to-the-test-patients-with-familial-exudative-vitreoretinopathy-fevr- 2024-12-16 0.50 https://www.ophthalmologytimes.com/view/european-medicines-agency-approves-faricimab-vabysmo-6-0-mg-single-dose-prefilled-syringe-rvo-dmo-dme-amd 2024-12-13 0.50 https://www.ophthalmologytimes.com/view/amd-halt-programme-receives-eurostars-grant-for-continued-investigation-of-dry-amd-gene-therapy-platform-phenocell-amarna-therapeutics-eureka-eu 2024-12-12 0.50 https://www.ophthalmologytimes.com/view/investigators-report-findings-on-serum-inflammatory-biomarkers-in-patients-with-macular-oedema 2024-12-12 0.50 https://www.ophthalmologytimes.com/view/myopia-control-study-demonstrates-4-year-results-of-diffusion-optics-technology-paediatric-cypress 2024-12-11 0.50 https://www.ophthalmologytimes.com/view/diabetic-eye-disease-where-are-we-now-european-association-for-the-study-of-diabetic-eye-complications-easdec-retina-oedema 2024-12-10 0.50 https://www.ophthalmologytimes.com/view/case-report-retinopathy-associated-with-the-use-of-hair-dye-aromatic-amines 2024-12-09 0.50 https://www.ophthalmologytimes.com/view/industry-updates-from-floretina-icoor-2024-retina-business-companies 2024-12-09 0.50 https://www.ophthalmologytimes.com/view/charles-wykoff-md-phd-presents-on-diabetic-retinopathy-and-the-dream-of-reperfusion-biomarkers-retinal-at-floretina-icoor-2024 2024-12-06 0.50 https://www.ophthalmologytimes.com/view/back-to-the-cornea-treating-hyperopic-patients-with-lenticule-extraction 2025-06-05 0.50 https://www.ophthalmologytimes.com/view/don-t-miss-our-editorial-advisory-board-members-at-the-floretina-icoor-meeting 2024-12-06 0.50 https://www.ophthalmologytimes.com/view/wet-amd-therapeutics-technologies-are-raising-the-ceiling-for-functional-visual-outcomes 2024-12-03 0.50 https://www.ophthalmologytimes.com/view/the-floretina-icoor-meeting-begins-in-florence-italy 2024-12-06 0.50 https://www.ophthalmologytimes.com/view/adapting-our-understanding-of-cerebral-visual-impairment-dorsal-and-ventral-visual-streams 2024-12-03 0.50 https://www.ophthalmologytimes.com/view/ethnic-background-has-an-impact-on-glaucoma-outcomes-united-kingdom-cohort 2024-12-03 0.50 https://www.ophthalmologytimes.com/view/recyclable-ophthalmic-instrument-company-hasa-optix-receives-b-corporation-certification 2024-12-02 0.50 https://www.ophthalmologytimes.com/view/factors-of-ocular-pain-and-dry-eye-disease-among-patients-on-the-tibetan-plateau-covid-19 2024-11-26 0.50 https://www.ophthalmologytimes.com/view/new-study-examines-rnfl-changes-and-association-with-bmi-tobacco-and-alcohol-use 2024-11-26 0.50 https://www.ophthalmologytimes.com/view/the-deep-dish-on-all-things-ophthalmology-at-aao-2024 2024-11-26 0.50 https://www.ophthalmologytimes.com/view/ema-orphan-medicinal-product-designation-ocu410st-ocugen-stargardt-retinitis-pigmentosa 2024-11-26 0.50 https://www.ophthalmologytimes.com/view/ocular-tuberculosis-and-relapse-rates-for-recurrence-of-uveitis-tb-uveitic-inflammation 2024-11-25 0.50 https://www.ophthalmologytimes.com/view/on-the-75th-anniversary-of-the-iol-modern-surgeons-pay-tribute-escrs-sir-harold-ridley-intraocular-lens 2024-11-25 0.50 https://www.ophthalmologytimes.com/view/arctic-vision-partners-with-santen-pharmaceutical-co-ltd-to-commercialise-arvn001-in-china 2024-11-22 0.50 https://www.ophthalmologytimes.com/view/incidence-of-microbial-keratitis-associated-with-overnight-orthokeratology 2024-11-21 0.50 https://www.ophthalmologytimes.com/view/european-commission-approves-aflibercept-biosimilar-opuviz-previously-sb15-from-samsung-bioepis 2024-11-20 0.50 https://www.ophthalmologytimes.com/view/chmp-issues-positive-opinion-for-marketing-authorisation-of-aflibercept-biosimilar-fyb203-formycon- 2024-11-19 0.50 https://www.ophthalmologytimes.com/view/us-fda-issues-complete-response-letter-for-avacincaptad-pegol-izervay-astellas-pharma-inc- 2024-11-19 0.50 https://www.ophthalmologytimes.com/view/nhs-introduces-oct-programme-to-reduce-annual-hospital-visits-for-patients-with-diabetes-optical-coherence-tomography-retinopathy 2024-11-18 0.50 https://www.ophthalmologytimes.com/view/choosing-the-specular-microscope-that-fits-your-clinic-nidek-tomey-cornea-endothelial-cell-density 2024-11-15 0.50 https://www.ophthalmologytimes.com/view/european-commission-grants-marketing-authorisation-for-aflibercept-biosimilar-afqlir-sandoz-group- 2024-11-15 0.50 https://www.ophthalmologytimes.com/view/canada-passes-national-strategy-for-eye-care-act 2024-11-14 0.50 https://www.ophthalmologytimes.com/view/how-a-gene-agnostic-approach-opens-doors-to-new-therapeutics-ocugen-ocu400-arun-upadhyay 2024-11-13 0.50 https://www.ophthalmologytimes.com/view/us-fda-clears-investigational-new-drug-application-for-crispr-cas13-rna-editing-therapy 2024-11-12 0.50 https://www.ophthalmologytimes.com/view/zooming-in-on-geographic-atrophy-with-oct-imaging-based-ai-artificial-intelligence 2024-11-08 0.50 https://www.ophthalmologytimes.com/view/aromatherapy-oculoplastic-surgery-recovery-may-lower-patients-postoperative-anxiety-and-pain 2024-11-07 0.50 https://www.ophthalmologytimes.com/view/innovation-and-the-clinician-scientist-gene-cell-therapy-industry 2024-11-06 0.50 https://www.ophthalmologytimes.com/view/recap-interviews-awards-leadership-at-the-2024-euretina-congress 2024-11-06 0.50 https://www.ophthalmologytimes.com/view/my-first-experiences-with-at-elana-841p-and-artevo-850 2025-10-27 0.50 https://www.ophthalmologytimes.com/view/playing-matchmaker-with-schlemm-canal-surgery-glaucoma 2024-11-04 0.50 https://www.ophthalmologytimes.com/view/study-caffeine-does-not-impact-retinal-vessel-density-despite-effects-on-blood-pressure 2024-11-05 0.50 https://www.ophthalmologytimes.com/view/global-research-team-develops-diagnostic-model-for-iris-melanoma 2024-10-31 0.50 https://www.ophthalmologytimes.com/view/aao-2024-main-takeaways-from-the-zoster-eye-disease-study-shingles-iritis-keratitis-valacyclovir 2024-11-04 0.50 https://www.ophthalmologytimes.com/view/efficiency-of-physiotherapy-in-treating-and-preventing-uncomplicated-acquired-myopia 2024-11-04 0.50 https://www.ophthalmologytimes.com/view/glaucoma-specialists-take-back-treatment-compliance 2024-10-30 0.50 https://www.ophthalmologytimes.com/view/higher-prevalence-of-dry-eye-disease-related-symptoms-in-south-america 2024-10-29 0.50 https://www.ophthalmologytimes.com/view/aao-2024-elevating-patient-care-through-progress-in-minimally-invasive-glaucoma-surgery 2024-10-28 0.50 https://www.ophthalmologytimes.com/view/ikerian-announces-commercial-expansion-of-retinai-discovery-in-europe-sanoptis 2024-10-25 0.50 https://www.ophthalmologytimes.com/view/aao-2024-new-data-illuminate-glaucoma-care-paradigms-for-surgical-interventions 2024-10-24 0.50 https://www.ophthalmologytimes.com/view/aao-2024-detail-outlined-for-artificial-intelligence-innovation-center-at-wilmer-eye-institute 2024-10-21 0.50 https://www.ophthalmologytimes.com/view/aao-2024-chloroprocaine-ophthalmic-gel-as-anesthesia-for-intravitreal-injections 2024-10-21 0.50 https://www.ophthalmologytimes.com/view/aao-2024-an-oral-anaesthetic-offers-relief-for-both-patients-and-care-teams 2024-10-23 0.50 https://www.ophthalmologytimes.com/view/aao-2024-early-cataract-extraction-for-angle-closure-glaucoma 2024-10-21 0.50 https://www.ophthalmologytimes.com/view/aao-2024-therapies-offering-hope-for-patients-diagnosed-with-ted 2024-10-20 0.50 https://www.ophthalmologytimes.com/view/ocuphire-pharma-and-opus-genetics-announce-merger 2024-10-22 0.50 https://www.ophthalmologytimes.com/view/aao-2024-myopic-lasik-performed-using-a-novel-excimer-laser 2024-10-20 0.50 https://www.ophthalmologytimes.com/view/aao-2024-approaching-pregnant-women-across-the-ophthalmic-subspecialties 2024-10-18 0.50 https://www.ophthalmologytimes.com/view/aao-2024-epimacular-membranes-and-metamorphopsia 2024-10-20 0.50 https://www.ophthalmologytimes.com/view/aao-2024-advancing-medical-education-with-ai-robotics-and-diverse-learning-methods 2024-10-27 0.50 https://www.ophthalmologytimes.com/view/aao-2024-transient-vision-loss-with-alexander-fein-md 2024-10-23 0.50 https://www.ophthalmologytimes.com/view/aao-2024-optimal-pupil-size-reduction-percentage-for-near-vision-improvement-in-presbyopia 2024-10-21 0.50 https://www.ophthalmologytimes.com/view/aao-2024-incidence-and-prevalence-of-uveitis-and-associated-ocular-complications-in-the-us-trinetx-database 2024-10-23 0.50 https://www.ophthalmologytimes.com/view/aao-2024-injectable-endothelial-cell-therapy-shows-promise-for-improving-vision-and-reducing-glare-in-corneal-edema 2024-10-20 0.50 https://www.ophthalmologytimes.com/view/aao-2024-two-year-clinical-feasibility-trial-outcomes-for-a-dual-optic-iol-system-for-the-treatment-of-presbyopia-and-cataract 2024-10-20 0.50 https://www.ophthalmologytimes.com/view/aao-2024-american-academy-ophthalmology-six-year-findings-from-laser-in-glaucoma-and-ocular-hypertension-light- 2024-10-17 0.50 https://www.ophthalmologytimes.com/view/aao-2024-take-home-results-from-1-year-of-ptk-assisted-customised-epi-on-cxl-different-approach-for-treating-keratoconus-eliza-pace-crosslinking-cornea 2024-10-14 0.50 https://www.ophthalmologytimes.com/view/aao-2024-clinical-trials-of-travoprost 2024-10-20 0.50 https://www.ophthalmologytimes.com/view/aao-american-academy-ophthalmology-2024-late-breaking-developments-in-a-novel-treatment-for-adolescents-with-stargardt-disease 2024-10-17 0.50 https://www.ophthalmologytimes.com/view/aao-2024-quantifying-risks-and-avoiding-posterior-capsular-rupture-in-the-second-eye 2024-10-15 0.50 https://www.ophthalmologytimes.com/view/aao-2024-american-academy-ophthalmology-focus-academic-perfomance-and-mental-health-outcomes-in-classroom-cell-phone-use 2024-10-17 0.50 https://www.ophthalmologytimes.com/view/aao-launches-vr-education-program-in-collaboration-with-fundamentalvr-to-improve-worldwide-ophthalmic-care 2024-10-18 0.50 https://www.ophthalmologytimes.com/view/ai-powered-home-monitoring-device-improved-amd-care-money-savings 2024-10-18 0.50 https://www.ophthalmologytimes.com/view/light-therapy-potential-treatment-for-dry-amd 2024-10-18 0.50 https://www.ophthalmologytimes.com/view/intravitreal-injections-for-amd-and-dme-may-complicate-cataract-surgery 2024-10-18 0.50 https://www.ophthalmologytimes.com/view/the-consequences-of-dry-eye-disease-incidence-of-psychiatric-disorders-fibromyalgia-and-chronic-fatigue-following-diagnosis-aao-academy 2024-10-17 0.50 https://www.ophthalmologytimes.com/view/gene-therapy-for-managing-neovascular-macular-degeneration 2024-10-16 0.50 https://www.ophthalmologytimes.com/view/german-ophthalmological-society-awards-theodor-leber-medal-honorary-society-memberships 2024-10-14 0.50 https://www.ophthalmologytimes.com/view/everything-to-know-about-the-2024-aao-american-academy-ophthalmology-meeting 2024-10-14 0.50 https://www.ophthalmologytimes.com/view/strabismus-surgery-glaucoma-s-unknowable-truths-and-other-aao-keynote-lecture-topics 2024-10-11 0.50 https://www.ophthalmologytimes.com/view/how-aao-2024-will-elevate-clinicians-skills-knowledge-and-experience-in-chicago 2024-10-10 0.50 https://www.ophthalmologytimes.com/view/children-across-the-uk-can-celebrate-world-sight-day-with-the-duchess-of-edinburgh 2024-10-09 0.50 https://www.ophthalmologytimes.com/view/ophthalmology-times-europe-parent-company-mjh-life-sciences-acquires-eye-care-conference-envision-summit 2024-10-11 0.50 https://www.ophthalmologytimes.com/view/the-true-costs-of-treating-paediatric-cataracts 2024-10-08 0.50 https://www.ophthalmologytimes.com/view/world-sight-day-is-thursday-10-october 2024-10-08 0.50 https://www.ophthalmologytimes.com/view/treatment-and-technology-the-future-of-retina-care-gene-therapy-robot 2024-10-07 0.50 https://www.ophthalmologytimes.com/view/the-black-box-of-artificial-intelligence-in-ophthalmology 2024-10-04 0.50 https://www.ophthalmologytimes.com/view/alzheimer-disease-retinopathy-and-brain-to-eye--amyloid-transport 2024-10-04 0.50 https://www.ophthalmologytimes.com/view/study-oral-caffeine-intake-increases-inner-electro-retinal-activity-in-young-adults 2024-10-03 0.50 https://www.ophthalmologytimes.com/view/what-missing-in-patient-education-diabetic-retinopathy-retina 2024-10-03 0.50 https://www.ophthalmologytimes.com/view/novaliq-and-laboratoires-th-a-announce-partnership-and-european-commission-approval-of-ciclosporin-0-1-eye-drops-solution 2024-10-02 0.50 https://www.ophthalmologytimes.com/view/novel-therapies-emerge-for-a-progressive-corneal-disease-fuchs-endothelial-dystrophy 2024-10-02 0.50 https://www.ophthalmologytimes.com/view/the-latest-genetic-research-from-this-summer-s-retina-conferences 2024-10-02 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-david-yorston-frcs-frcophth-says-data-can-unify-us 2024-09-30 0.50 https://www.ophthalmologytimes.com/view/enhancing-the-cataract-patient-journey-and-solutions-for-streamlining-surgical-success 2025-03-05 0.50 https://www.ophthalmologytimes.com/view/enhancing-the-glaucoma-patient-journey-and-solutions-to-overcoming-challenges-in-glaucoma-management 2025-03-05 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-ultra-widefield-oct-and-the-benefits-of-improved-imaging 2024-09-27 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-the-cooperative-work-of-an-international-team 2024-09-27 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-crispr-cas-mediated-base-editing-approaches-for-crb1-related-retinal-dystrophy 2024-09-27 0.50 https://www.ophthalmologytimes.com/view/aurion-biotech-announces-commercial-launch-of-neltependocel-vyznova-in-japan 2024-09-27 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-therapeutics-for-wet-amd-address-the-broader-vegf-family 2024-09-26 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-carl-awh-md-fasrs-and-the-american-society-of-retina-specialists-collaborate-at-euretina 2024-09-26 0.50 https://www.ophthalmologytimes.com/view/eu-chmp-confirms-negative-opinion-on-marketing-authorisation-application-of-intravitreal-pegcetacoplan-from-apellis 2024-09-25 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-genotype-phenotype-correlations-in-a-cohort-of-patients-with-genetically-determined-retinitis-pigmentosa 2024-09-25 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-the-global-voyager-study-provides-real-world-scalable-findings 2024-09-25 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-bahram-bodaghi-md-phd-febo-says-the-congress-starts-with-innovation- 2024-09-25 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-the-future-of-medical-retina-is-brilliant-for-clinicians-and-patients 2024-09-24 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-aleksandra-rachitskaya-md-fasrs-and-the-vit-buckle-society-come-to-barcelona 2024-09-24 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-martin-s-zinkernagel-md-phd-on-the-future-of-real-world-ai-use 2024-09-23 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-alexandra-miere-md-phd-sees-oculomics-rising-to-the-top 2024-09-23 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-factors-predictive-of-macular-oedema-development-in-patients-with-silicone-oil-tamponade 2024-09-16 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-tyrosine-kinase-inhibitors-and-safety-data-for-patients-with-non-proliferative-diabetic-retinopathy 2024-09-22 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-boris-stanzel-md-shares-research-on-fluid-monitoring-and-fixation-clouds 2024-09-22 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-kyoko-ohno-matsui-md-phd-delivers-a-keynote-on-cutting-edge-technologies-for-pathologic-myopia 2024-09-21 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-keynote-speaker-yousif-subhi-md-phd-on-keeping-patients-in-focus 2024-09-21 0.50 https://www.ophthalmologytimes.com/view/ema-announces-positive-opinion-for-sb15-opuviz-samsung-bioepis-and-biogen- 2024-09-20 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-subretinal-drusenoid-deposit-load-and-correlation-with-an-increased-risk-of-stroke 2024-09-20 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-andrea-govetto-md-phd-says-it-takes-teamwork-to-understand-macular-oedema 2024-12-06 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-unraveling-the-genetic-spectrum-of-combined-retinal-dystrophy-and-hearing-impairment 2024-09-17 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-ricardo-leita-o-guerra-md-msc-fico-speaks-about-multimodal-imaging 2024-09-18 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-subretinal-gene-therapy-improves-function-and-structure-in-patients-with-bothnia-dystrophy 2024-09-19 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-ocular-involvement-among-patients-with-covid-19-infection-or-vaccination 2024-09-16 0.50 https://www.ophthalmologytimes.com/view/johnson-johnson-vision-supports-ec-survey-on-potential-electronic-instructions-for-use-expansion 2024-09-23 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-cardio-ocular-syndrome-and-retinal-microvasculature-changes-in-acute-heart-failure 2024-09-16 0.50 https://www.ophthalmologytimes.com/view/euretina-2024-efficacy-results-and-patient-preference-findings-from-the-pagoda-trial 2024-09-17 0.50 https://www.ophthalmologytimes.com/view/study-examines-navigation-performance-in-glaucoma-with-virtual-reality-based-assessment-of-path-integration 2024-09-16 0.50 https://www.ophthalmologytimes.com/view/see-what-our-editorial-advisory-board-members-are-bringing-to-euretina 2024-09-12 0.50 https://www.ophthalmologytimes.com/view/industry-preview-ophthalmic-companies-bring-updates-new-research-findings-to-euretina 2024-09-12 0.50 https://www.ophthalmologytimes.com/view/celebrate-world-retina-day-at-the-2024-euretina-congress 2024-09-10 0.50 https://www.ophthalmologytimes.com/view/24th-euretina-congress-the-art-of-retina-on-stage-in-barcelona 2024-09-10 0.50 https://www.ophthalmologytimes.com/view/remembering-a-legend-euretina-members-speak-about-the-ramin-tadayoni-award 2024-12-18 0.50 https://www.ophthalmologytimes.com/view/trinity-team-s-gene-therapy-offers-promising-glaucoma-and-amd-treatment 2024-09-09 0.50 https://www.ophthalmologytimes.com/view/escrs-2024-approaching-a-paradigm-shift-in-cell-therapy-for-corneal-oedema-and-endothelial-dysfunction 2024-09-09 0.50 https://www.ophthalmologytimes.com/view/icare-debuts-slit-lamp-mounted-st500-tonometer 2024-09-09 0.50 https://www.ophthalmologytimes.com/view/escrs-2024-a-new-edof-iol-brings-functional-outcomes-into-the-spotlight 2024-09-07 0.50 https://www.ophthalmologytimes.com/view/escrs-2024-36-month-results-following-femtosecond-image-guided-high-precision-trabeculotomy-flight- 2024-09-09 0.50 https://www.ophthalmologytimes.com/view/magnetic-cell-therapy-for-corneal-endothelial-dysfunction 2024-09-05 0.50 https://www.ophthalmologytimes.com/view/unite-and-conquer-refractive-surgery-goes-on-a-world-tour-escrs-moving-simulator 2024-09-04 0.50 https://www.ophthalmologytimes.com/view/filomena-ribeiro-md-phd-febo-discusses-escape-rooms-inclusivity-initiatives-and-everything-else-escrs 2024-09-04 0.50 https://www.ophthalmologytimes.com/view/bvi-announces-launch-of-serenity-and-serenity-toric-iols-at-escrs 2024-09-03 0.50 https://www.ophthalmologytimes.com/view/corneal-nerve-regeneration-following-semaglutide-therapy 2024-09-04 0.50 https://www.ophthalmologytimes.com/view/european-commission-grants-marketing-authorization-for-treatment-of-acanthamoeba-keratitis 2024-08-30 0.50 https://www.ophthalmologytimes.com/view/the-digital-or-retina-care-of-tomorrow 2024-09-04 0.50 https://www.ophthalmologytimes.com/view/research-illustrates-impact-of-vitamin-d-supplementation-rvo-preventing-retinal-vein-occlusion 2024-08-28 0.50 https://www.ophthalmologytimes.com/view/a-field-guide-to-optic-disc-drusen 2024-08-27 0.50 https://www.ophthalmologytimes.com/view/rayner-announces-launch-of-rayone-galaxy-spiral-iol 2024-08-26 0.50 https://www.ophthalmologytimes.com/view/the-shifting-landscape-of-conjunctival-hyperemia 2024-08-22 0.50 https://www.ophthalmologytimes.com/view/phase-1-2-study-suggests-efficacy-of-novel-eye-drop-to-reverse-cataracts 2024-08-21 0.50 https://www.ophthalmologytimes.com/view/research-indicates-long-term-effect-of-covid-19-on-corneal-endothelial-cell-morphology 2024-08-20 0.50 https://www.ophthalmologytimes.com/view/why-the-future-of-glaucoma-care-is-in-the-operating-room 2024-08-12 0.50 https://www.ophthalmologytimes.com/view/the-champ-clinical-trial-and-nvk002-for-controlling-paediatric-myopia 2024-08-12 0.50 https://www.ophthalmologytimes.com/view/ranibizumab-biosimilar-lubt010-lupin-reaches-primary-endpoint-in-global-phase-3-study 2024-08-12 0.50 https://www.ophthalmologytimes.com/view/us-fda-issues-approval-for-sandoz-aflibercept-abzv-enzeevu- 2024-08-12 0.50 https://www.ophthalmologytimes.com/view/optimizing-diagnosis-and-surgical-management-of-diabetic-retinopathy-using-advanced-imaging-technologies 2025-02-03 0.50 https://www.ophthalmologytimes.com/view/going-for-gold-the-new-standard-for-cross-linking-cxl-keratoconus 2024-12-19 0.50 https://www.ophthalmologytimes.com/view/untangling-the-genetic-secrets-of-retinoblastoma 2024-08-09 0.50 https://www.ophthalmologytimes.com/view/asrs-abroad-retina-specialists-converge-in-sweden 2024-08-08 0.50 https://www.ophthalmologytimes.com/view/lensar-receives-certification-for-new-adaptive-cataract-treatment-system 2024-08-07 0.50 https://www.ophthalmologytimes.com/view/combining-outdoor-time-and-spectacle-lenses-for-myopia-management 2024-08-07 0.50 https://www.ophthalmologytimes.com/view/vision-loss-cholesterol-identified-as-risk-factors-associated-with-dementia 2024-08-05 0.50 https://www.ophthalmologytimes.com/view/august-is-children-paediatric-eye-health-and-safety-month 2024-08-02 0.50 https://www.ophthalmologytimes.com/view/european-commission-issues-approval-for-faricimab-vabysmo-for-treatment-of-retinal-vein-occlusion 2024-07-31 0.50 https://www.ophthalmologytimes.com/view/kiora-pharmaceuticals-receives-orphan-medicinal-product-designation-for-kio-301 2024-07-30 0.50 https://www.ophthalmologytimes.com/view/vialase-laser-receives-ce-mark-announces-eu-distribution-partners 2024-07-30 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-real-world-treatment-outcomes-from-a-study-of-patients-with-retinal-vein-occlusion 2024-07-30 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-real-world-impact-of-vitrectomy-surgery-on-age-related-macular-degeneration 2024-07-29 0.50 https://www.ophthalmologytimes.com/view/novaliq-receives-positive-chmp-opinion-for-vevizye-in-treatment-of-dry-eye-disease 2024-07-29 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-neurotech-pharmaceuticals-update-on-the-nt-501-device 2024-07-25 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-assessing-retinal-vascular-changes-in-alzheimer-disease-with-radiomics-a-preliminary-study-of-fundus-photography 2024-07-25 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-durability-of-combination-therapy-of-sozinibercept-in-namd-and-dme 2024-07-25 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-real-world-namd-data-demonstrate-aflibercept-8-mg-outcomes 2024-07-25 0.50 https://www.ophthalmologytimes.com/view/photon-results-and-their-relation-to-dme-patients-in-your-practice 2024-07-25 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-clinical-characterisation-of-hk1-associated-with-retinitis-pigmentosa 2024-07-25 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-sickle-cell-retinopathy-and-measurements-with-dynamic-oct-angiography 2024-07-25 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-social-determinants-of-vision-health-in-patients-with-rhegmatogenous-retinal-detachments 2024-07-29 0.50 https://www.ophthalmologytimes.com/view/pulsar-results-and-their-relation-to-namd-patients-in-your-practice 2024-07-25 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-examining-36-month-outcomes-of-fluocinolone-acetonide-0-18-with-the-calm-registry-study 2024-07-24 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-a-novel-approach-to-myopic-traction-maculopathy-suspensory-macular-buckling 2024-07-23 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-aflibercept-8-mg-and-2-mg-dme-and-iop-outcomes-in-the-phase-2-3-photon-trial 2024-07-23 0.50 https://www.ophthalmologytimes.com/view/higher-molar-dose-and-its-translation-into-clinical-practice 2024-08-07 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-multiwavelength-photobiomodulation-significantly-reduces-risk-for-vision-loss-and-onset-of-ga-in-dry-amd 2024-07-21 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-intraoperative-fluorescein-angiography-reduces-the-rate-of-postoperative-vitreous-hemorrhage 2024-07-23 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-long-term-results-of-macular-hole-surgery-with-long-acting-gas-tamponade-ilm-peeling 2024-07-20 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-100-week-results-from-the-restore-trial-showcase-retinitis-pigmentosa-outcomes 2024-07-19 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-diabetic-retinopathy-lesions-and-assessing-disease-severity-over-time 2024-11-22 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-iop-outcomes-following-suprachoroidal-triamcinolone-acetonide-use-in-non-infectious-uveitis 2024-07-19 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-first-time-results-from-a-phase-1b-study-of-fas-inhibition-with-onl-1204 2024-07-19 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-examining-real-world-use-of-faricimab-through-the-faretina-dme-study 2024-07-18 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-geographic-atrophy-findings-from-part-1-of-the-phase-2-3-siglec-trial 2024-07-18 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-continuous-treatment-of-dme-with-a-port-delivery-system-for-ranibizumab 2024-07-18 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-72-week-results-from-the-phase-3-balaton-and-comino-trials 2024-07-18 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-sustainability-expert-panel-demonstrates-how-retina-specialists-practices-go-green 2024-07-18 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-geographic-atrophy-lesion-growth-and-outer-retinal-tubulation-non-subfoveal 2024-07-18 0.50 https://www.ophthalmologytimes.com/view/what-are-attendees-most-looking-forward-to-at-this-year-s-asrs-meeting- 2024-07-17 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-improving-octa-performance-using-ai-and-differential-artery-vein-analysis-diabetic-retinopathy 2024-07-17 0.50 https://www.ophthalmologytimes.com/view/industry-preview-eye-care-companies-announce-presentations-ahead-of-asrs-meeting 2024-07-16 0.50 https://www.ophthalmologytimes.com/view/alopecia-areata-and-underlying-corneal-pathologies 2024-07-15 0.50 https://www.ophthalmologytimes.com/view/impact-report-highlights-outcomes-of-moorfields-eye-charity-programmes 2024-07-12 0.50 https://www.ophthalmologytimes.com/view/vegf-c-and-vegf-d-signaling-pathways-potential-targets-for-treating-wet-amd 2024-07-11 0.50 https://www.ophthalmologytimes.com/view/semaglutide-may-be-associated-with-non-arteritic-ischemic-optic-neuropathy-naion- 2024-07-09 0.50 https://www.ophthalmologytimes.com/view/beacon-therapeutics-announces-new-board-members-series-b-funding-to-support-xlrp-and-dry-amd-programmes 2024-07-08 0.50 https://www.ophthalmologytimes.com/view/preview-the-american-society-of-retina-specialists-meets-in-stockholm-sweden 2024-07-08 0.50 https://www.ophthalmologytimes.com/view/visual-and-refractive-outcomes-of-a-combined-opposite-clear-corneal-incision-procedure 2024-07-05 0.50 https://www.ophthalmologytimes.com/view/july-is-dry-eye-awareness-month-resources-from-prevent-blindness 2024-07-04 0.50 https://www.ophthalmologytimes.com/view/altos-biologics-submits-ema-marketing-authorisation-application-for-aflibercept-biosimilar-alt-l9 2024-07-03 0.50 https://www.ophthalmologytimes.com/view/ema-issues-positive-chmp-opinion-for-faricimab-vabysmo-in-third-indication-retinal-vein-occlusion 2024-07-02 0.50 https://www.ophthalmologytimes.com/view/us-fda-approves-aflibercept-mrbb-ahzantive-eylea-biosimilar-from-formycon 2024-07-02 0.50 https://www.ophthalmologytimes.com/view/eu-chmp-issues-negative-opinion-on-apellis-maa-application-for-pegcetacoplan-syfovre-injection 2024-07-02 0.50 https://www.ophthalmologytimes.com/view/insights-into-neovascular-glaucoma-pathogenesis-and-detection-of-diabetic-retinopathy 2024-07-01 0.50 https://www.ophthalmologytimes.com/view/asrs-2024-industry-updates-and-new-research-findings-expected-at-this-year-s-meeting 2024-07-01 0.50 https://www.ophthalmologytimes.com/view/post-hoc-analyses-of-yosemite-rhine-trials-compare-faricimab-results-to-aflibercept 2024-06-28 0.50 https://www.ophthalmologytimes.com/view/inaugural-ramin-tadayoni-award-will-be-granted-at-2024-euretina-congress-oculis-retina 2024-06-27 0.50 https://www.ophthalmologytimes.com/view/novel-tactile-bottle-neck-adaptor-facilitates-eye-drop-adherence-in-visually-impaired-patients 2024-06-25 0.50